Symposium 2019

Where is life science heading in the future: Technology driven science and healthcare: New oppurtunities and potential risks

May 9-10th 2019, Engelsberg Ironworks

How are artificial intelligence and new technologies within genetics transforming life science and healthcare today in Sweden and globally? The development is rapidly unleashing new possibilities to understand life threatening disease and to allow development of novel treatments.
How does large scale genome sequencing bring value to people and society? What are the consequences of having advanced gene editing tools accessible to everyone? When can you expect that the artificial intelligence bot in your mobile phone tells you to seek medical help before you have felt any symptoms of a coming heart attack?

Program

Moderator: Ingrid Heath – Senior Advisor, Adlersson heath 

ARTIFICIAL INTELLIGENCE – AN INTRODUCTION

What is artificial intelligence? How will artificial intelligence affect our society and industries? How can we live and work in harmony with intelligent machines? 

  • Magnus Boman – Professor of Intelligent Software Systems at KTH Royal Institute of Technology 
  • Stefan Larsson – Associate Professor in Technology and Social Change, Lund University 

ARTIFICIAL INTELLIGENCE IN HEALTHCARE 

How is artificial intelligence applied in healthcare today? What are the opportunities and challenges? From scientific applications to clinical practices – how to implement safely? 

  • Indra Joshi –  Clinical Lead, Digital Health and Artificial Intelligence, NHS UK 
  • Henrik Grönberg – Professor of Cancer Epidemiology, Karolinska Institutet 

ENGINEERING LIVING THINGS – A PRACTICAL PERSPECTIVE

  • Andrew Hessel – CEO Humane Genomics Inc. 

ADVANCED BIOTECHNOLOGY MADE ACCESSIBLE – EXTENSIVE OPPORTUNITIES AND POTENTIAL RISKS

Estonia is offering free gene tests to 8% of their population. How can large scale genetic screening help improve the health situation? How are the new tools for genetic engineering used to understand biology and medicine?  Making genetic engineering accessible to everyone – what are the benefits and potential risks of “DIY science”? New tools provide considerable possibilities, but what is ethical and what isn’t? And furthermore, what should be prioritized from the economics perspective?

  • Lili Milani – Head of Personalized Medicine & Research, Professor at Estonian Genome Center
  • Fredrik Lanner – at Department for Clinical Science, Intervention and Technology, Karolinska Institutet
  • Bethan Wolfenden – Co-founder of Bento Bio
  • Lars Sandman – Professor and Director at National Centre of Priority Setting in Healthcare, Linköping University

HEALTH, BIOTECHNOLOGY AND INTELLIGENT MACHINES: HOW DO WE PREPARE FOR THE FUTURE?

Technology advances are happening fast and in every domain – How can we design strategies for the future? How can policy developments keep the pace with science and technology advances? How can instances of the personal integrity be balanced with the need for data to advance new healthcare technologies and ensure steady progress in medical research? An ever-increasing number of diseases are becoming treatable – great news, but it also put pressure on healthcare budgets. How will we be able to prioritize?

  • Jenni Nordborg – Director, National Coordinator Life Sciences at the Government Offices of Sweden & Head of Health Division at Vinnova